Q4 2019 Holdings
Filed 2020-01-21 | 7 holdings | $331.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $256.1M | 4,205,615 | 77.2% |
| Veracyte, Inc.(VCYT) | Common Stock | 92337F107 | $33.7M | 1,205,407 | 10.1% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $27.8M | 3,102,929 | 8.4% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $8.8M | 2,215,384 | 2.6% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $3.3M | 4,492,975 | 1.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $1.1M | 543,753 | 0.3% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $1.1M | 101,855 | 0.3% |